PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported January 22, 2025

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of …

Recall #
Z-0921-2025
Affected scope
10 units
Initiated
October 7, 2024
Verify with FDA Devices →
View my saved recalls

Drg International, Inc. recalled DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 - a moderate-severity action.

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 was recalled by Drg International, Inc. in January 22, 2025. Reason: The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument usi…. Check the official notice for the remedy. Verify recall #Z-0921-2025 with the FDA Devices before acting.

The recall

Drg International, Inc. issued this moderate-severity FDA Devices recall-The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument usi….

Moderate
severity level
10 units
affected scope
Class II
classification
January 22, 2025
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-0921-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Reason for recall

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-0921-2025
Date reported January 22, 2025
Date initiated October 7, 2024
Recalling firm Drg International, Inc.
Firm location Springfield, NJ
Affected scope 10 units
Distribution Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

10 units units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-0921-2025) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361. Recalled by Drg International, Inc.. Units affected: 10 units.
Why was this product recalled?
The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 22, 2025. Severity: Moderate. Recall number: Z-0921-2025.
Where was the recalled product distributed?
Distribution: Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported January 22, 2025. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026